Patients with advanced breast cancer are being denied access to life-prolonging drug – Eurekalert

Lisbon, Portugal: Survival for patients with the most common forms of advanced breast cancer could be substantially improved if both younger and older patients had access to a group of anti-cancer drugs called CDK4/6 inhibitors, according to experts at the Advanced Breast Cancer Fifth International Consensus Conference (ABC5) in Lisbon today (Saturday). [1]

In a session agreeing new guidelines for treating advanced breast cancer, they said there was now enough evidence that this class of medicines helps patients live longer and with the same or better quality of life. However, they said…